320 related articles for article (PubMed ID: 20189481)
1. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.
Kim HS; Das A; Gross CC; Bryceson YT; Long EO
Immunity; 2010 Feb; 32(2):175-86. PubMed ID: 20189481
[TBL] [Abstract][Full Text] [Related]
2. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
Bryceson YT; Ljunggren HG; Long EO
Blood; 2009 Sep; 114(13):2657-66. PubMed ID: 19628705
[TBL] [Abstract][Full Text] [Related]
3. Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity.
Yin S; Zhang J; Mao Y; Hu Y; Cui L; Kang N; He W
J Biol Chem; 2013 Sep; 288(37):26448-62. PubMed ID: 23897818
[TBL] [Abstract][Full Text] [Related]
4. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells.
Kim HS; Long EO
Sci Signal; 2012 Jul; 5(232):ra49. PubMed ID: 22786724
[TBL] [Abstract][Full Text] [Related]
5. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
[TBL] [Abstract][Full Text] [Related]
6. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
7. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
8. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
[TBL] [Abstract][Full Text] [Related]
9. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
Ding Y; Sumitran S; Holgersson J
Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
[TBL] [Abstract][Full Text] [Related]
10. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
Lin Chua H; Brahmi Z
Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
[TBL] [Abstract][Full Text] [Related]
11. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
[TBL] [Abstract][Full Text] [Related]
12. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
13. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F; Kabat J; Sanni TB; Coligan JE
J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
[TBL] [Abstract][Full Text] [Related]
14. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.
Lee JE; Lim SA; Kim TJ; Kim K; Ng J; Kim YH; Jang IJ; Oh SB; Lee JC; Yee C; Kumar V; Lee KM
Eur J Immunol; 2014 Jun; 44(6):1802-13. PubMed ID: 24610736
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
16. HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway.
Wu L; Zhang C; Zhang J
Cell Mol Immunol; 2011 Sep; 8(5):433-40. PubMed ID: 21706044
[TBL] [Abstract][Full Text] [Related]
17. CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway.
Hernández-Caselles T; Miguel RC; Ruiz-Alcaraz AJ; García-Peñarrubia P
J Immunol Res; 2019; 2019():6032141. PubMed ID: 31143782
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk.
Peterson ME; Long EO
Immunity; 2008 Oct; 29(4):578-88. PubMed ID: 18835194
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E.
Carretero M; Llano M; Navarro F; Bellón T; López-Botet M
Eur J Immunol; 2000 Oct; 30(10):2842-8. PubMed ID: 11069065
[TBL] [Abstract][Full Text] [Related]
20. NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.
Wu X; Sharma A; Oldenburg J; Weiher H; Essler M; Skowasch D; Schmidt-Wolf IGH
Front Immunol; 2021; 12():731767. PubMed ID: 34691037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
